Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $11.8400 (-10.24%) ($11.5700 - $12.7100) on Mon. Feb. 24, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.82% (three month average) | RSI | 42 | Latest Price | $11.8400(-10.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -3.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(49%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -1.91% in a week (0% probabilities). VIXM(-37%) VXX(-36%) TLT(-11%) UNG(-7%) UUP(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.91% (StdDev 3.82%) | Hourly BBV | 0 () | Intraday Trend | -6.5% | | | |
|
1 - 5 Day Possible Target | $3.98(-66.39%) | Resistance Level | $13.86 | 5 Day Moving Average | $13.57(-12.75%) | 10 Day Moving Average | $13.84(-14.45%) | 20 Day Moving Average | $13.86(-14.57%) | To recent high | -33.4% | To recent low | 0% | Market Cap | $880m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |